Clinical Trials for Amplia Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Amplia Therapeutics

Clinical Trials (2)

A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer

PHASE1/PHASE2Recruiting

67 participants

Started: Aug 18, 2025 · Completed: Jul 31, 2029

1 condition1 sponsor2 locations

ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer

PHASE1/PHASE2Active, not recruiting

62 participants

Started: May 31, 2022 · Completed: May 1, 2026

3 conditions1 sponsor13 locations